Search Orphan Drug Designations and Approvals
-
Generic Name: | Ofloxacin | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | Ocuflox Ophthalmic Solution | ||||||||||||||||
Date Designated: | 04/18/1991 | ||||||||||||||||
Orphan Designation: | Treatment of bacterial corneal ulcers. | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
Allergan, Inc. 2525 Dupont Drive P.O. Box 19534 Irvine, California 92713 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | Ofloxacin |
---|---|---|
Trade Name: | Ocuflox Ophthalmic Solution | |
Marketing Approval Date: | 05/22/1996 | |
Approved Labeled Indication: | Treatment of bacterial corneal ulcers. | |
Exclusivity End Date: | 05/22/2003 | |
Exclusivity Protected Indication* : | ||
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-